These findings provide a link for future clinically focused research to evaluate how orthodontic treatments are affected by elevated GDF15 blood levels, as seen in patients with advanced age and pathologic conditions such as inflammation, myocardial ischemia, and cancer [43]. The gene discussed is GDF15; the disease is cancer.